Press-release for stocks in the health technology sector

sector : Health technology crawled date : 2021 - 10 - 28

save search

Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals
Published: 2021-10-28 (Crawled : 23:00) - prnewswire.com
INVA | $14.955 1.8% 1.77% 640K

Health Technology

| -16.35% | O: -0.58% H: 3.66% C: 1.39%
ARMP | $2.61 2.35% 2.11% 9.6K

Health Technology

| -15.0% | O: 13.33% H: 0.0% C: -5.88%
fibrosis cystic fibrosis

Life Sciences Industry Sees Burst of Job and Facility Expansions in October
Published: 2021-10-28 (Crawled : 23:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -11.48% | O: 0.02% H: 0.87% C: -0.56%
expansion life science

Global Nicotine Gum Market Report 2021: Emergence of e-Cigarettes has Considerably Challenged Market Growth
Published: 2021-10-28 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| -0.88% | O: 1.37% H: 0.0% C: 0.0%
PRGO | $30.8 2.87% -1.14% 1.2M

Health Technology

| -32.72% | O: -0.31% H: 1.77% C: 1.44%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 11.73% | O: -0.84% H: 0.18% C: 0.18%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -10.99% | O: -0.31% H: 0.55% C: 0.33%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| -5.98% | O: -0.33% H: 0.86% C: 0.83%
growth merge market

Aravive Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
ARAV | $0.0401 4.74% 4M

Health Technology

| -98.72% | O: 1.24% H: 0.0% C: -1.22%
financial results results

Acutus Medical to Announce Third Quarter 2021 Financial Results
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
AFIB | $0.167 -4.3% -4.49% 400K

Health Technology

| -97.81% | O: 2.06% H: 3.29% C: 3.16%
financial results results

Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
TVTX | $5.73 -1.21% -1.22% 950K

Health Technology

| -77.14% | O: 0.15% H: 2.86% C: 1.33%
financial results results

Atara Biotherapeutics to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M

Health Technology

| -95.45% | O: 0.2% H: 4.26% C: 4.2%
financial results results iot

Sangamo Therapeutics Announces Third Quarter 2021 Conference Call and Webcast
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M

Health Technology

| -93.48% | O: 0.25% H: 4.31% C: 4.13%
conference therapeutics

Gilead Sciences Announces Third Quarter 2021 Financial Results
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M

Health Technology

| 0.19% | O: -0.1% H: 1.44% C: 0.96%
financial results results

Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
A | $132.73 0.22% 0.0% 1.3M

Health Technology

| -11.89% | O: 0.46% H: 1.16% C: -0.14%
presentation financial results results

Bio-Rad Reports Third-Quarter 2021 Financial Results
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
BIO | News | $279.73 -0.46% 0.0% 290K

Health Technology

| -64.32% | O: 0.67% H: 3.26% C: 2.48%
financial results results

Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® (sacituzumab govitecan-hziy) in Combination With KEYTRUDA® (pembrolizumab) in Patients With First-Line Metastatic Triple-Negative Breast Cancer
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M

Health Technology

| 0.19% | O: -0.1% H: 1.44% C: 0.96%
collaboration cancer breast cancer trial keytruda

Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
A | $132.73 0.22% 0.0% 1.3M

Health Technology

| -11.89% | O: 0.46% H: 1.16% C: -0.14%
europe cancer breast cancer diagnostic

STERIS Declares $0.43 per share Dividend
Published: 2021-10-28 (Crawled : 22:00) - globenewswire.com
STE | $199.51 -0.65% 0.0% 530K

Health Technology

| -14.04% | O: -0.15% H: 0.75% C: 0.49%

Reata Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Bardoxolone Methyl in Chronic Kidney Disease Caused by Alport Syndrome
Published: 2021-10-28 (Crawled : 21:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0

Health Technology

| 79.39% | O: 0.23% H: 3.98% C: 0.03%
disease europe application kidney syndros

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
Published: 2021-10-28 (Crawled : 21:00) - biospace.com/
RMD | $178.85 0.7% 0.0% 1.2M

Health Technology

| -35.17% | O: 0.53% H: 2.27% C: -0.33%
results